Patents by Inventor Daisuke Nambara

Daisuke Nambara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9175084
    Abstract: The present invention enables to realize a convenient determination of a therapeutic effect of an anticancer agent on a cancer.
    Type: Grant
    Filed: March 18, 2011
    Date of Patent: November 3, 2015
    Assignee: FUJIREBIO INC.
    Inventors: Nobuyuki Ise, Daisuke Nambara, Kazuya Omi
  • Patent number: 9157905
    Abstract: The present invention provides a methodology that can develop a more excellent anti-cancer drug than conventional ones for various cancers. Specifically, the present invention provides a method for establishing an artificial cell, comprising treating a cancer cell with an expression vector for a foreign oncogene and then culturing the cancer cell treated with the expression vector under a condition which inhibits an expression or function of an oncogene that is inherent to the cancer cell, and an established artificial cell; a method of screening an anti-cancer drug, comprising evaluating whether or not a test substance inhibits a proliferation of the artificial cell; as well as a method for identifying an oncogene, comprising treating a cancer cell with an expression vector for a test gene and then culturing the cancer cell treated with the expression vector under a condition which inhibits an expression or function of an oncogene that is inherent to the cancer cell.
    Type: Grant
    Filed: February 21, 2011
    Date of Patent: October 13, 2015
    Assignee: FUJIREBIO INC.
    Inventors: Nobuyuki Ise, Kazuya Omi, Daisuke Nambara
  • Publication number: 20130029357
    Abstract: The present invention enables to realize a convenient determination of a therapeutic effect of an anticancer agent on a cancer.
    Type: Application
    Filed: March 18, 2011
    Publication date: January 31, 2013
    Applicant: FUJIREBIO INC.
    Inventors: Nobuyuki Ise, Daisuke Nambara, Kazuya Omi
  • Publication number: 20120315628
    Abstract: The present invention provides a methodology that can develop a more excellent anti-cancer drug than conventional ones for various cancers. Specifically, the present invention provides a method for establishing an artificial cell, comprising treating a cancer cell with an expression vector for a foreign oncogene and then culturing the cancer cell treated with the expression vector under a condition which inhibits an expression or function of an oncogene that is inherent to the cancer cell, and an established artificial cell; a method of screening an anti-cancer drug, comprising evaluating whether or not a test substance inhibits a proliferation of the artificial cell; as well as a method for identifying an oncogene, comprising treating a cancer cell with an expression vector for a test gene and then culturing the cancer cell treated with the expression vector under a condition which inhibits an expression or function of an oncogene that is inherent to the cancer cell.
    Type: Application
    Filed: February 21, 2010
    Publication date: December 13, 2012
    Applicant: FUJIREBIO INC.
    Inventors: Nobuyuki Ise, Kazuya Omi, Daisuke Nambara